NCT06704724

A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.

The trial was terminated for strategic business reasons; the decision was not based on any safety and/or efficacy concerns.